ZENAS BIOPHARMA Trademark

Trademark Overview


On Friday, June 28, 2024, a trademark application was filed for ZENAS BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the ZENAS BIOPHARMA trademark a serial number of 98625409. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, January 24, 2025. This trademark is owned by Zenas BioPharma, Inc.. The ZENAS BIOPHARMA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations in the nature of auto-immune and immune-based therapies for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune and immune-based diseases

Development of pharmaceutical preparations and medicines; scientific and medical research services; pharmaceutical development services, namely, development of auto-immune and immune-based therapies
zenas biopharma

General Information


Serial Number98625409
Word MarkZENAS BIOPHARMA
Filing DateFriday, June 28, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, January 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the wording "ZENAS BIOPHARMA" and a lightning bolt design to the left of the wording.
Goods and ServicesPharmaceutical preparations in the nature of auto-immune and immune-based therapies for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of auto-immune and immune-based diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDevelopment of pharmaceutical preparations and medicines; scientific and medical research services; pharmaceutical development services, namely, development of auto-immune and immune-based therapies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZenas BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events


Event DateEvent Description
Wednesday, December 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 23, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, June 28, 2024NEW APPLICATION ENTERED
Wednesday, December 11, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 11, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 23, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 24, 2025ASSIGNED TO EXAMINER
Friday, January 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 24, 2025NON-FINAL ACTION WRITTEN
Friday, January 24, 2025NON-FINAL ACTION E-MAILED
Monday, February 3, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 3, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 3, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED